D&P Labo Overview
- Year Founded
-
2020
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
D&P Labo General Information
Description
Operator of a drug discovery platform intended to selectively act and treat endometriosis. The company specializes in the research and development of bio-peptide and diagnostic drugs, focusing on the gynecological and malignant tumor fields, enabling patients to regain healthy lives.
Contact Information
Website
www.dp-labo.co.jpCorporate Office
- Fujita Health University, 1-98 Tarakugakubo
- Kutsukake-cho
- Toyoake, Aichi 470-1192
- Japan
Corporate Office
- Fujita Health University, 1-98 Tarakugakubo
- Kutsukake-cho
- Toyoake, Aichi 470-1192
- Japan
D&P Labo Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 02-Oct-2024 | Completed | Out of Business | |||
| 2. Seed Round | 30-Jul-2020 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 04-Feb-2020 | Completed | Startup |
D&P Labo FAQs
-
When was D&P Labo founded?
D&P Labo was founded in 2020.
-
Where is D&P Labo headquartered?
D&P Labo is headquartered in Toyoake, Japan.
-
What industry is D&P Labo in?
D&P Labo’s primary industry is Drug Discovery.
-
Is D&P Labo a private or public company?
D&P Labo is a Private company.
-
What is D&P Labo’s current revenue?
The current revenue for D&P Labo is .
-
How much funding has D&P Labo raised over time?
D&P Labo has raised $337K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process